Form CORRESP - Correspondence:
SEC Accession No. 0001193125-25-009609
Filing Date
2025-01-21
Accepted
2025-01-21 17:01:49
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 35663
2 GRAPHIC g769642dsp1.jpg GRAPHIC 6465
3 GRAPHIC g769642dsp1a.jpg GRAPHIC 5554
  Complete submission text file 0001193125-25-009609.txt   53486
Mailing Address 171 OYSTER POINT BOULEVARD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BOULEVARD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 6508505070
Maze Therapeutics, Inc. (Filer) CIK: 0001842295 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)